Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status: A Randomized Controlled Trial (BBTBBT)

NCT04508244 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04508244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04508244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status: A Randomized Controlled Trial (BBTBBT)
Lead sponsor
Hamad Medical Corporation
Phase
Phase 4
Overall status
Unknown status
Start date
December 29, 2020
Completion date
December 31, 2024
Enrollment
771 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

beta blockers, brain injuries, stress reaction, trauma, troponin